3 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow ALT-836: new trials by email Literature Review of ALT-836 trials Research Report on ALT-836
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors ALT-836 in combination with gemcitabine - Locally Advanced Malignant Neoplasm, Malignant Solid Tumour | Phase 1 | Completed | Altor BioScience | 30 | 2011-05-01 | 2016-07-15 |
| Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome ALT-836, Placebo - Sepsis, Acute Lung Injury | Phase 2 | Completed | Altor BioScience | 150 | 2009-04-01 | 2015-04-10 |
| Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome TNX-832, Placebo - Sepsis, Acute Lung Injury | Phase 1 | Completed | Altor BioScience | 18 | 2004-12-01 | 2025-01-06 |
Acute Lung Injury (2) · Lung Diseases (2) · Respiratory Distress Syndrome (2) · Sepsis (2) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Colonic Neoplasms (1) · Head and Neck Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Prostatic Neoplasms (1) · Sarcoma (1) · Venous Thromboembolism (1)
Altor BioScience (3)
United States (3) · Canada (1)
Hing C Wong, PhD (1) · Hing Wong, PhD (1)